| 000 | 01816 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513184727.0 | ||
| 264 | 0 | _c19990811 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0021-9150 | ||
| 024 | 7 |
_a10.1016/s0021-9150(99)00062-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRiegger, G | |
| 245 | 0 | 0 |
_aThe effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment. _h[electronic resource] |
| 260 |
_bAtherosclerosis _cMay 1999 |
||
| 300 |
_a263-70 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aCoronary Disease _xcomplications |
| 650 | 0 | 4 |
_aCoronary Vessels _xdrug effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aExercise Tolerance _xdrug effects |
| 650 | 0 | 4 |
_aFatty Acids, Monounsaturated _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluvastatin |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aHyperlipidemias _xcomplications |
| 650 | 0 | 4 |
_aIndoles _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTunica Intima _xdiagnostic imaging |
| 650 | 0 | 4 | _aUltrasonography |
| 700 | 1 | _aAbletshauser, C | |
| 700 | 1 | _aLudwig, M | |
| 700 | 1 | _aSchwandt, P | |
| 700 | 1 | _aWidimsky, J | |
| 700 | 1 | _aWeidinger, G | |
| 700 | 1 | _aWelzel, D | |
| 773 | 0 |
_tAtherosclerosis _gvol. 144 _gno. 1 _gp. 263-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0021-9150(99)00062-3 _zAvailable from publisher's website |
| 999 |
_c10339724 _d10339724 |
||